Feb 6, 2017 by Brian FeroldiWhy Aratana Therapeutics Inc. Is Tumbling TodayShares fall in response to news of a delayed product launch.
Feb 6, 2017 by Brian FeroldiWhy Pacific Biosciences of California Jumped 10.5% in JanuaryA handful of positive announcements allowed shares to bounce back from December's drubbing.
Feb 6, 2017 by Brian FeroldiHere's Why MannKind Corporation Rose 11.5% in JanuaryA handful of positive developments caused shares to rally.
Feb 6, 2017 by Brian Feroldi5 Must-Read Quotes From Skyworks Solutions' Latest Investor CallFrom efforts to diversify the business to growth opportunities ahead, these quotes will help investors better understand the semiconductor specialist's future.
Feb 6, 2017 by Brian Feroldi3 of the Highest-Growth Stocks in the Market TodayThese three stocks promise fast growth for those daring enough to invest.
Feb 5, 2017 by Brian Feroldi3 Reasons TransEnterix Inc Stock Could FallTransEnterix's long-term market performance has been horrific. Here are three reasons to believe that the pain could continue.
Feb 4, 2017 by Brian Feroldi10 Highest Dividend-Yielding StocksThese 10 income stocks offer up huge dividend yields, but are any of them actually worth buying?
Feb 3, 2017 by Brian FeroldiWhy Esperion Therapeutics, Inc. Is Soaring TodayPositive clinical news at Amgen caused a handful of analysts to issue bullish comments on Esperion's stock.
Feb 3, 2017 by Brian Feroldi3 Stocks You Can Buy and Hold for the Next Decade Looking for a few stocks that you can safely buy and hold for years on end? Consider giving these three wide-moat stocks a closer look.
Feb 2, 2017 by Brian FeroldiHere's Why NIC Inc. Is Plunging TodayShares fell after management reported guidance for the year ahead that failed to impress.
Feb 2, 2017 by Brian FeroldiHere's Why AMAG Pharmaceuticals Is Falling TodayShares dropped after the company reported mixed top-line data from an important clinical trial.
Feb 2, 2017 by Brian FeroldiNIC Inc. Reports Strong Quarterly Results, Disappointing GuidanceThe government-portal operator said 2017 will be an investment year for the business.
Feb 2, 2017 by Brian FeroldiHere's Why MannKind Corporation Is PlungingShares fell hard after management announced that a reverse stock split might be in the cards.
Feb 2, 2017 by Brian FeroldiWhy Halozyme Therapeutics, Inc. Jumped 15.6% in JanuaryShares rose in response to the release of upbeat clinical data from an important phase 2 study.
Feb 2, 2017 by Brian Feroldi3 Stocks to Buy With Dividends Yielding More Than 3%These three stocks offer up a nice combination of growth, value, and yield.
Jan 31, 2017 by Brian Feroldi, Dan Caplinger, Evan Niu, CFA, Tyler Crowe, Neha Chamaria, Timothy Green, and George Budwell, PhD7 Top Stocks to Buy in FebruaryOur team of Foolish contributors thinks these seven stocks are all strong buys right now.
Jan 30, 2017 by Brian Feroldi, Keith Speights, and Todd CampbellWhy You're Right to Invest in Gilead Sciences StockWorried that the bull thesis in Gilead has gone awry? Here are three reasons you shouldn't give up just yet.
Jan 30, 2017 by Brian Feroldi3 Reasons TransEnterix Inc Stock Could RiseShares collapsed in 2016 in response to an FDA rejection. Here's what it will take for this stock to regain its momentum.
Jan 28, 2017 by Brian FeroldiBetter Buy: Skyworks Solutions Inc. vs. InfineraWhich of these two tech companies is the better bet for new money today?
Jan 28, 2017 by Brian Feroldi, Dan Caplinger, and Tyler Crowe3 Small-Cap Stocks to Buy in FebruaryHere's why our team of Fools thinks that Douglas Dynamics, Denbury Resources, and STAG Industrial are great small-cap stocks to buy right now.
